Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Other Non-Current Assets (2016 - 2019)

Historic Other Non-Current Assets for Soleno Therapeutics (SLNO) over the last 6 years, with Q3 2019 value amounting to $59000.0.

  • Soleno Therapeutics' Other Non-Current Assets fell 9303.42% to $59000.0 in Q3 2019 from the same period last year, while for Sep 2019 it was $59000.0, marking a year-over-year decrease of 9303.42%. This contributed to the annual value of $516000.0 for FY2017, which is 6766.93% down from last year.
  • Latest data reveals that Soleno Therapeutics reported Other Non-Current Assets of $59000.0 as of Q3 2019, which was down 9303.42% from $847000.0 recorded in Q3 2018.
  • In the past 5 years, Soleno Therapeutics' Other Non-Current Assets ranged from a high of $2.3 million in Q2 2017 and a low of $59000.0 during Q3 2019
  • Moreover, its 5-year median value for Other Non-Current Assets was $484000.0 (2018), whereas its average is $613846.9.
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first skyrocketed by 295657.89% in 2017, then tumbled by 9303.42% in 2019.
  • Over the past 5 years, Soleno Therapeutics' Other Non-Current Assets (Quarter) stood at $718003.0 in 2015, then surged by 122.28% to $1.6 million in 2016, then plummeted by 67.67% to $516000.0 in 2017, then skyrocketed by 64.15% to $847000.0 in 2018, then crashed by 93.03% to $59000.0 in 2019.
  • Its Other Non-Current Assets was $59000.0 in Q3 2019, compared to $847000.0 in Q3 2018 and $470000.0 in Q2 2018.